Several b b-carbolines including naturally occurring substances and their corresponding cationic derivatives were synthesized and evaluated for antimalarial (antiplasmodial) activity in vitro and in vivo. A tetracyclic carbolinium salt was elucidated for antileishmanial and antitrypanosomal activities in vitro as well as antiplasmodial activity. Quarternary carbolinium cations showed much higher potencies in vitro than electronically neutral b b-carbolines and a good correlation was observed between p p-delocalized lipophilic cationic (DLC) structure and antimalarial efficacy. b b-Carbolinium compounds exhibit medium suppressive activity in vivo against rodent malaria.
Malaria, which is caused by plasmodium protozoa, is one of the most serious infectious disease as well as HIV and tuberculosis. The disease exists in 100 countries but is mainly confined to tropical areas of Africa, Asia and South America. More than one million people, most occurring in infants and young children, die annually from malaria, and disease burden is estimated at 42 million DALYs (disable adjusted life years). 1) Another tropical parasitic diseases, such as leishmaniasis (Kara azar, oriental sore), African trypanosomasis (African sleeping sickness) and American trypanosomasis (Chagas disease), which are called as "neglected diseases", also prevent social and economical development in those countries.
2) Despite of the tremendous toll, effective treatments and prevention for the diseases are quite difficult; no vaccine is available in clinically use: limited chemotherapeutics, even including some drawbacks, are available: parasites develop resistance against clinically used drug: and so on. 3) So that, development of new class of antiprotozoal including antimalarial agents are required and the efforts are steadily increasing in non-profit institutions. 4) Recently we have reported the rhodacyanines, having a pdelocalized lipophilic cationic (DLC) structure, exhibit in vitro strong antiplasmodial and antileishmanial activities against Plasmodium falciparum 5, 6) and against Leishmania major, 7) respectively, with low cytotoxicity against mammalian cell. The conceptual term, DLC, was originally proposed by Chen in their anticancer research work.
8) It has subsequently been reported several DLC compounds exhibit selective antitumor activity by their selective accumulation in the mitochondria of carcinoma cells. [9] [10] [11] Namely, lipophilic cations possessing a delocalized positive charge (DLCs) penetrate the hydrophobic barriers of the plasma and mitochondria membrane in response to the negative inside transmembrane potentials. The higher mitochondrial membrane potentials of carcinoma cells compared to normal cells induce the selective transfer of DLCs into carcinoma mitochondria. Since most DLCs are toxic to mitochondria at high concentrations, their selective accumulation in carcinoma mitochondria and consequent mitochondrial toxicity provide a basis for selective carcinoma cell killing. It has been reported by Vaidya et al. that collapse of mitochondrial membrane potential in a malarial parasites is observed by the treatment with antimalarial drugs.
12) Consequently, we envisaged that DLCs would be a new candidate for the chemotherapeutics of malaria as well as another neglected diseases.
b-Carboline alkaloids are widely found in a number of plants and mammalian species. Some of these alkaloids, such as manzamine A, 10-hydroxycanthin-6-one and akagerine (Chart 1), exhibit a variety of biological and pharmaceutical potencies including antiplasmodial activity. [13] [14] [15] Pavanand et al. isolated the simple b-carboline, 4-methoxy-1-vinyl-b-carboline; (MVC, 1a; Chart 1) 16) and related compounds as antiplasmodial components from Picrasma javanica B1, a medicinal plant used for the treatment of malaria. 17) However their antiplasmodial activities are not so strong as alternatives for a clinical use. We considered that b-carbolines could be easily transformed into DLCs by means of quarternarization of the pyridine nitrogen atom and the resulting b-carbolinium salts may have higher antiplasmodial properties than neutral carbolines. Herein, we report the synthesis of b-carboline compounds and their quarternary salts, and we evaluate their in vitro antiprotozoal activities and cell cytotoxicity. Moreover, antimalarial efficacy in vivo was evaluated using malaria-infected mice.
(DIBAL-H) at Ϫ78°C to produce aldehyde 1f (kumujancine) in 96% yield; Kumujancine is a natural b-carboline isolated from the wood of Picrasma quassioide. 24) Finally, Wittig olefination of 1f afforded 1a in 51% yield. It is noteworthy that we first achieved the total synthesis of the two natural products, MVC (1a) and kumujancine (1f). Transformation of 1f into 1a was also achieved by stepwise synthesis via alcohol 1g by methylation, followed by dehydration.
Synthesis of unnatural 4-methoxy-1-methyl-b-carboline (1c) was started from tryptamine hydrochloride (2) and aqueous acetaldehyde. N-Benzoyl-tetrahydro-b-carboline 3c was synthesized by Pictet-Spengler reaction, followed by benzoylation. Oxidation of 3c with DDQ afforded desired 4-oxotetrahydrocarboline 4c and 2-acetylindole 5 in 43% and 20% yield, respectively. Compound 4c was isolable by silica gel chromatography and showed better stability than 4a. Byproduct 5 would be produced by oxidation of 3c at C-1 position and subsequent hydration. Oxidation of 1-methyltetrahydrocarboline 3c would occur competitively at C-1 and C-4 position because of the small electrochemical difference. Further oxidation of 4c by p-chloranil, followed by methylation, gave 1c. 4-Unsubstituted analogs 1e and 1h-j were prepared by the similar procedure as the synthesis of 1a. Pictet-Spengler reaction of tryptamine hydrochloride (2) with ethyl glyoxylate, followed by direct oxidative aromatization by Pd/C catalyst, yielded kumujian A (1e). Kumujian C (1h), 23) alcohol 1i, 25) and pavettine (1j), 26) which all are naturally occurring products, were prepared in due course. Canthin-6-one (1k) 27) was synthesized from aldehyde 1h in a single operation. 28) Thus, acetylation and consequent intramolecular aldol condensation occurred by the reaction of 1h with acetyl chloride in the presence of triethylamine. Harmane (1l) and harmine (1o) were purchased, and crenatine (1b), 1m, 1n and 1p were synthesized according as known procedures. 20, 21, 29) b-Carbolinium salts 6, which correspond to DLCs, were synthesized from the corresponding b-carbolines 1 by the simple quarternarization with alkyl tosylate or alkylhalide (Chart 3). Preparation of chloride salts 6cc and 6ce-cj was achieved by ion exchange operation from the corresponding tosylate or iodide salts (Table 1) . 30) Dicationic salt 6n was prepared from 1n by the treatment of excess amount of methyl tosylate, and tetracyclic compound 6q was synthesized from harmine (1o) according as the reported procedure (Chart 4). 31, 32) Dihydro-b-carbolinium salt 8, which lacks of one conjugation in the aromatic system (thus, non-DLC), was prepared from 7. N-Methyl deprotonated analogs 9l and 9o were quantitatively obtained by the treatment of the corresponding b-carbolinium salts 6l and 6o, respectively, with aqueous NaOH.
33)
Evaluation of Antiplasmodial Activity in Vitro The antiplasmodial potencies of the b-carbolines 1, b-carbolinium salts 6 and related compounds 7-9 were evaluated in vitro against P. falciparum (chloroquine sensitive FCR-3 strain) and their cytotoxicities were determined using mouse mammary tumor FM3A cells. Selective toxicities, defined by the ratio EC 50 (FM3A)/EC 50 (P. falciparum), were determined. The biological results are summarized in Table 2 . Electronically neutral b-carbolines 1a-c, 1o and 1p displayed weak to medium inhibitory effects against P. falciparum (EC 50 ϭ0. 5-3.1ϫ10 Ϫ5 M), and their cytotoxicities were comparable to their antiplasmodial activity levels (runs 1-5). In contrast, N-alkyl carbolinium salts 6 displayed considerably enhanced antiplasmodial activities (runs 6-23) except for 6d, 6m and 6n. Introduction of a methyl and ethyl group on the pyridine nitrogen atom of 1a resulted in a 5-fold and a 39-fold increase in antiplasmodial activity, respectively (1a versus 6aa or 6ab). In addition, the cytotoxicity levels of these substances were decreased 2-3-fold by quarternarization. A similar enhancement of antiplasmodial effectiveness was observed by the transformation of carbolines 1 into the corresponding carbolinium salts 6 (1b versus 6b, 1c versus 6c, 1o versus 6o, and 1p versus 6pa or 6pb). In particular, 6pa showed a 67-fold increase in an antiplasmodial activity compared to the corresponding 1p. These results indicate that DLC compounds have increased antiplasmodial potency within the class of b-carbolines by simple transformation. In contrast, quarternarization of dihydro-b-carboline had no effect in biological activity; both the electronically neutral molecule 7 and cationic salt 8 displayed similarly low antiplasmodial activities (runs 24, 25) . Deprotonated analogs 9 having no charge were less active than the corresponding cations 6 (runs 26 versus 18, and 27 versus 21). On the other hand, dicationic salt 6n showed no inhibitory effect against P. falciparum even in high concentration (Ͼ2ϫ10 Ϫ6 M) although its cytotoxicity level was pretty high (run 20). Accordingly, these findings further indicate that a broad delocalized system and the cationic charge on the delocalized system, that is a DLC structure, are critical factors in the biological properties of this family of compounds. [34] [35] [36] [37] A structure-activity relationship (SAR) analysis concerning R 1 -R 5 substituents was also undertaken. The introduction of a methoxyl group as an R 1 or R 2 substituent caused a 2-fold (6l versus 6o) or 3-fold (6l versus 6cb) enhancement in activity against P. falciparum, whereas the cytotoxicities of these substances were decreased by these substitutions. In contrast, substitution of R 3 with phenyl or ethoxycarbonyl groups resulted in a remarkable decrease in antiplasmodial activity (runs 14, 19) , and introduction of an a-hydroxyethyl substituent lead slightly loss in the activity (run 16). The introduction of a substituent at the indole-NH by a methyl group caused an increase in activity (6o versus 6pa). The protection of indole nitrogen atom might inhibit conversion into an electronically neutral molecule under cellular conditions (Chart 5). 38) Probably, according as the same reason, tetracyclic canthin-6-one analog 6k displayed good antiplasmodial property. Replacement of methyl group as an R 5 substituent by an ethyl group resulted in a 10-fold increase in antiplasmodial potency for 6ab (versus 6aa), but a 2-fold decrease in activity was observed for 6ce (versus 6cc). b-Hydroxyethyl substituent for R 5 group also lead decrease in activity (6pa versus 6pb). It was observed that counter anion (X Ϫ ) affected antiplasmodial properties to some extent (runs 9, 11, 12) . The difference might be caused by the solubility of the substances in aqueous media. Among our tested compounds, 2-ethyl-4-methoxy-1-vinyl-b-carbolinium p-toluenesulfonate (6ab) was found to display good antiplasmodial efficacy. Its selective toxicity was less than that of quinine, which is an antimalarial medicine in current clinical use, but its antiplasmodial activity against P. falciparum is comparable. It is additionally noteworthy that 6ca is effective even against chloroquine resistant parasites (P. falciparum K1 strain) with EC 50 values of 3.6ϫ10 Ϫ7 M (run 10).
Antiprotozoal Activity of Tetracyclic Cation 6q in Vitro
For tetracyclic compound 6q, various antiprotozoal properties including antimalarial activity were examined in vitro (Table 3) . Antileishmanial (Kara azar), anti-African-trypanosomal (African sleeping sickness), anti-American-trypanosomal (Chagas disease) and antigiargial (diarrhoeal giardiasis) activities were determined as EC 50 values against the following parasites; L. donovani, T. brucei rhodesiense, T. cruzi and Giardia lamblia, respectively. 33) G. lamblia is categorized as a class of diplonadida parasites, which have no mitochondrial organelle in its cell. The other tested parasites possess parasitic mitochondria in their cells. Cell cytotoxicity was tested using L-6 (a rat skeletal myoblast cell line). Interestingly, compound 6q showed good inhibitory effect within a range of 2.6-10ϫ10 Ϫ7 M against all parasites except for G. lamblia. The efficacies of 6q against the parasites were com-656
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Leishmania donovani inf, macrophages 1.0ϫ10
Trypanosoma brucei rhodesiense 6.3ϫ10
Trypanosoma cruzi 4.5ϫ10
Cytotoxicity L-6 4.9ϫ10
Chart 5 parable to the corresponding chemotherapeutics in clinically use, and the cytotoxicity level of 6q was about 10-fold less than its antiprotozoal activity. Antileishmanial activity of 6q was observed against not only axenic leishmania parasites but also ones infected to macrophages (runs 2, 3). Evaluation of Antimalarial Activity in Vivo Several bcarbolinium salts 6 were subjected to in vivo assay for their effects on the suppression of parasitemia in malaria (P. berghei)-infected mice. Preliminary toxic study has revealed that compounds 6ab and 6q show acute toxicity to normal mice by intraperitoneal (i.p.) injection at a dose of more than 50 and 200 mg kg Ϫ1 d
Ϫ1
, respectively. In vivo antimalarial assay was carried out using Peters' 4-d suppressive test. 39, 40) Compound 6ab displayed an antimalarial activity at a dose of 10 mg kg Ϫ1 d Ϫ1 of body weight by i.p. injection (26% suppression of parasitemia; Table 4 , run 1). However, no significant increase in efficacy was observed even at a dose of 20 mg kg Ϫ1 d Ϫ1 (run 2). The antimalarial properties were displayed by intravenous (i.v.) injection even at smaller doses (2.5-5.0 mg kg Ϫ1 d Ϫ1 ) (runs 3, 4). However, treatment by i.v. injection at a higher dose produced side effects (acute toxicity).
As the results, all compounds were tested at doses of 10 mg kg Ϫ1 of body weight by i.p. injection. The results are summarized in Table 4 . The similar toxic effect was observed for compound 6ce; it showed 21% suppression by i.p. injection, whereas deaths of all mice by acute toxicity were observed by i.v injection at the same dose (run 5 versus run 7). Some of the tested compounds 6g and 6q were found to display a greater in vivo activity than compound 6ab (runs 13, 14) . These in vivo results indicate that further studies for biological effects in host animals, such as bioavailability and clearance, are indispensable.
In summary, we have synthesized b-carbolines and their corresponding salts, including several naturally occurring compounds, and evaluated them for their antimalarial potency in vitro. The b-carbolinium salts, which have a DLC (p-delocalized lipophilic cationic) structure, show a higher antiplasmodial potency and better selective toxicity than non-DLC compounds. Some of the b-carbolinium salts have in vivo antimalarial potency to a certain extent. Thus, this study indicates that transformation into a DLC structure may prove to be a highly effective modification methodology in the antimalarial medicinal chemistry. Tetracyclic b-carbolinium analog 6q also displays good antileishmanial and antitrypanosomal properties as well as antimalarial activity.
Experimental
Melting points (mp) were measured with a Yanaco micro melting point apparatus and are uncorrected. UV and fluorescence spectra were recorded with a BECKMAN DU-640 and a Hitachi F 2000 spectrometers, respectively. IR spectra were recorded with a SHIMADZU FTIR-8300.
1 H-and 13 C-NMR spectra (400, 100 MHz, respectively) were recorded on a JEOL AL400 spectrometer. Chemical shifts were relative to tetramethylsilane (TMS). Fast atom bombardment (FAB) mass spectra were determined with a JEOL JMS DX-303 mass spectrometer. Electron ionization (EI) mass spectra were recorded on a JEOL JMS AX-500 instrument. Elemental analyses were performed on Yanagimoto MT-3, and the results (C, H, N) were within Ϯ0.4% of theoretical values. All reactions were carried out under an argon atmosphere. Unless otherwise described, the materials and the solvent were obtained by reaction of commercial suppliers and used without further purification.
Ethyl 2-Acetyl-1,2,3,4-tetrahydro-b b-carboline-1-carboxylate (3a) To a suspension of tryptamine hydrochloride (2; 17.1 g, 86.9 mmol) in ethanol (200 ml) was added a solution of glyoxylic acid ethyl ester (21.4 g, 105 mmol) in toluene (50% v/v) at 0°C. After the reaction mixture was stirred over night at ambient temperature, solvent was removed under reduced pressure. The resulting residue was treated with sat. NaHCO 3 , and was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated in vacuo. The crude product was used in the next step without further purification. To a solution of the above residue and DMAP (0.131 g, 0.925 mmol) in CH 2 Cl 2 (200 ml) at 0°C were added Et 3 N (15.5 ml, 111 mmol) and AcCl (7.89 ml, 111 mmol). The mixture was stirred over night at ambient temperature. After concentration under reduced pressure, the residue was treated with sat. NaHCO 3 , and was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated in vacuo. The residue was chromatographed on silica gel with AcOEt-hexane (1 : 1) to give compound 3a (11.0 Ethyl 4-Methoxy-b b-carboline-1-carboxylate (1d) Compound 3a (3.00 g, 10.5 mmol) and DDQ (11.9 g, 52.4 mmol) were mixed together until a uniform color was observed. The mixture of powders was cooled on a dry ice-acetone bath. The aqueous THF (THF-H 2 Oϭ9 : 1 v/v; 70 ml) was added slowly to the mixture of powders. The reaction mixture was stirred at Ϫ78°C for 1 h, and then allowed to warm to ambient temperature. After the reaction mixture was stirred over night at ambient temperature, solvent was removed under reduced pressure. The residue was treated with sat. NaHCO 3 , and extracted with CHCl 3 . The combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated in vacuo. The crude product of 4a was used in the next step without further purification. A solution of ptoluenesulfonic acid monohydrate (2.40 g, 12.6 mmol) in benzene (70 ml) was heated under azeotropic conditions for 2 h, and then cooled to ambient temperature. To the mixture were added 2,2-dimethoxypropane (3.87 ml, 31.5 mmol), followed by the above the crude product of 4a, and the resulting mixture was stirred at ambient temperature for 30 min. Then, to the mixture was added p-chloranil (5.16 g, 21.0 mmol), and was further stirred over night at the same temperature. After concentration of the solution in vacuo, the residue was treated with CHCl 3 and sat. NaHCO 3 . The aqueous phase was extracted with CHCl 3 and the combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated. The residue was chromatographed on silica gel with AcOEt-hexane (1 : 1) to give 1d (884 mg, 30%) as colorless solids and 1e (195 4-Methoxy-b b-carboline-1-carbaldehyde (Kumujancine; 1f) To a stirred solution of 1d (468 mg, 1.73 mmol) in CH 2 Cl 2 (30 ml) was added DIBAL-H solution (1.0 M in hexane; 12.1 ml, 12.1 mmol) at Ϫ50°C. The mixture was stirred at Ϫ50°C for 10 min and quenched by sequential addition of MeOH (14.0 ml) and 10% NaOH (9.53 ml) at Ϫ50°C. Then the mixture was stirred at ambient temperature for an additional 1 h. The precipitates were removed through a Celite ® and washed with CHCl 3 -MeOH (10 : 1). The combined filtrate was washed with brine, dried over Na 2 SO 4 and concentrated under reduced pressure. Recrystallization from CH 2 Cl 2 -hexane gave compound 1f (376 mg, 96%) as yellow solids. The spectral data were identical with reported ones.
24)
1- (1-Hydroxyethyl)-4-methoxy-b b-carboline (1g) To a stirred solution of 1f (100 mg, 0.442 mmol) in THF (2.0 ml) was added MeLi (1.2 M in Et 2 O; 1.33 ml, 1.60 mmol) at Ϫ78°C. The mixture was stirred at the sam temperature for 10 min, quenched by addition of MeOH, and concentrated in vacuo. The residue was treated with sat. NaHCO 3 , and extracted with ethyl acetate. The combined organic phases were washed with brine, dried over Na 2 
4-Methoxy-1-vinyl-b b-carboline (MVC; 1a) From 1f:
To a stirred solution of methyltriphenylphosphonium iodide (413 mg, 1.02 mmol) in THF (5 ml) was added n-BuLi (1.59 M in hexane; 0.611 ml, 0.971 mmol) at 0°C. The mixture was then stirred at ambient temperature for 2 h. A solution of 1f (55 mg, 0.243 mmol) in THF (5 ml) was added to the above mixture at 0°C, and then the whole were heated at 70°C for 2 h. The reaction mixture was quenched by addition of NH 4 Cl at 0°C, followed by NaHCO 3 , and extracted with CHCl 3 . The combined organic phases were washed with brine, dried over Na 2 SO 4 , and concentrated. The residue was chromatographed on silica gel with AcOEt-hexane (1 : 1) to 1a (27.5 mg, 51%) as yellow solids. The spectral data were identical with reported ones. 16) From 1g: To a solution of 1g (50 mg, 0.206 mmol) in CH 2 Cl 2 (0.50 ml) at 0°C were added Et 3 N (144 ml, 1.03 mmol) and MsCl (24.0 ml, 0.310 mmol). The reaction mixture was stirred at ambient temperature for 8 h, and then quenched by addition of H 2 O at 0°C. After extraction with CHCl 3 , the combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated. The residue was chromatographed on silica gel with toluene-acetone (7 : 1) to give compound 1a (8.6 mg, 19%) as yellow solids, whose spectral data were identical with reported ones. Ethyl b b-Carboline-1-carboxylate (Kumujian A; 1e) A suspension of tryptamine hydrochloride (2; 8.00 g, 40.7 mmol) in ethanol (150 ml) was added a solution of glyoxylic acid ethyl ester (12.5 g, 61.2 mmol) in toluene (50% v/v) at 0°C. After the reaction mixture was stirred over night at ambient temperature, solvent was removed under reduced pressure. The resulting residue was treated with sat. NaHCO 3 , and was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated in vacuo. The crude product was used in the next step without further purification. To a solution of the resulting crude residue in pxylene (100 ml) at 0°C was added 10% Pd/C (2.17 g), and the mixture was stirred over night at 140°C under an air atmosphere. The resulting solids were removed through Celite ® and washed with CHCl 3 . After concentration of the filtrate, the resulting residue was chromatographed on silica gel with toluene-acetone (7 : 1) to give compound 1e (4.01 g, 41%) . Recrystallization from acetone gave colorless solids, whose spectral data were identical with reported ones. 23) b b-Carboline-1-carbaldehyde (Kumujian C; 1h) Compound 1h was obtained in a similar manner to the synthesis of 1f (89% yield). The spectral data were identical with reported ones.
23)
1-(1-Hydroxyethyl)-b b-carboline (1i) Compound 1i was obtained in a similar manner to the synthesis of 1h (79% yield). The spectral data were identical with reported ones.
25)
1-Vinyl-b b-carboline (Pavettine; 1j) Compound 1j was obtained from 1i in a similar manner to the synthesis of 1a from 1g (18% yield). The spectral data were identical with reported ones.
26)
Canthin-6-one (1k) To a stirred suspension of sodium hydride (5.0 mg, 0.125 mmol) in THF (0.5 ml) were added 1h (20 mg, 0.102 mmol) and, then, AcCl (9.0 ml, 0.127 mmol) at 0°C. The mixture was stirred for 5 h at ambient temperature. After removal of the solvent under reduced pressure, the resulting residue was treated with sat. NaHCO 3 and extracted with ethyl acetate. The combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated. The residue was chromatographed on silica gel with AcOEt-hexane (1 : 1) to give compound 1k (6.9 mg, 31%) as yellow solids. The spectral data were identical with reported ones. 33 (1H, d, Jϭ8.4 Hz), 8.21 (1H, s), 7.72 (2H, m), 7.42 (1H, m) 137.3, 136.3, 131.9, 129.6, 126.7, 125.9, 123.0, 119.5, 118.2, 111.5, 58.0,  55.2, 34.0, 21.3, 16.3 Compound 6cd (100 mg, 0.242 mmol) was treated with 10% KOH aq. (10 ml), and extracted with AcOEt. The combined organic phases were washed with brine, dried over Na 2 SO 4 , and concentrated. Mixture of the resulting residue and methyl p-toluenesulfonate (90.2 mg, 0.484 mmol) was stirred for 18 h at 80°C. After cooling to ambient temperature, the resulting precipitate was collected by filtration, which was subjected to ion exchange polymer (Amberlyte IRA-400) to give 6cj (53. 5 42) were supplied by the Japanese Cancer Research Resources Bank (JCRB). FM3A cells were maintained in suspension culture at 37°C in a 5% CO 2 atmosphere in plastic bottles containing ES medium (Nissui Pharmaceuticals, Tokyo, Japan) supplemented with 2% heat-inactivated fetal bovine serum (Gibco, NY, U.S.A.).
Evaluation of in Vitro Antiplasmodial Activity The following procedures were used for assay of antimalarial activity (except for run 24 in Table  2) 43,44) Asynchronously cultivated P. falciparum were used. Various concentrations of compounds in dimethylsulfoxide (DMSO) were prepared. 5 ml of each solution was added to individual wells of a multidish, 24 wells. Erythrocytes with 0.3% parasitemia were added to each well containing 995 ml of culture medium to give a final hematocrit level of 3%. The plates were incubated at 37°C for 72 h in a CO 2 -O 2 -N 2 incubator (5% CO 2 , 5% O 2 , and 90% N 2 atmosphere). To evaluate the antimalarial activity of test compound, we prepared thin blood films from each culture and stained them with Giemsa (E. Merck, Germany). Total 1ϫ10 4 erythrocytes/1 thin blood film were examined under microscopy. All of the test compounds were assayed in duplicate at each concentration. Drug-free control cultures were run simultaneously. All data points represent the mean of three experiments. Parasitemia in control reached between 4% and 5% at 72 h. The EC 50 value refers to the concentration of the compound necessary to inhibit the increase in parasite density at 72 h by 50% of control.
In vitro antiplasmodial activity against for compound 6q was assessed using an adaptation of the procedures ( 3 H-hypoxanthine incorporation assay). 45, 46) Evaluation of Cytotoxicity against Mammalian Cell Line FM3A cells grew with a doubling time of about 12 h. Prior to exposure to drugs, cell density was adjusted to 5ϫ10 4 cells/ml. A cell suspension of 995 ml was dispensed to the test plate, and compound at various concentrations suspended in DMSO (5 ml) was added to individual wells of a multidish, 24 wells. The plates were incubated at 27°C in a 5% CO 2 atmosphere for 48 h. All of the test compounds were assayed in duplicate at each concentration. Cell numbers were measured using a microcell counter CC-130 (Toa Medical Electric Co., Japan). All data points represent the mean of three experiments. The EC 50 value refers to the concentration of the compound necessary to inhibit the increase in cell density at 48 h by 50% of control. Selectivity refers to the mean of EC 50 value for FM3A cells per the mean of EC 50 value for P. falciparum.
Evaluation of Antileishmanial, Antitrypanosomal Activities in Vitro Evaluation against the protozoa L. donovani (axenic and infected amastigotes), T. brucei rhodesiense (STIB900) and T. cruzi, G. lamblia and for cytotoxicity on L6 cells was performed according to experimental procedures described elswhere. [46] [47] [48] Evaluation of in Vivo Antiplasmodial Activity In vivo antimalarial activities of b-carbolinium salts were determined in mice infected with P. berghei (NK 65 strain). 39, 40) Five-week-old ICR male mice obtained in sterile containers from Japan SLC, Inc. (Hamamatsu, Japan) weighing 22-25 g were used. They were housed under a natural day-night cycle at 25°C. The mice were randomly assigned to treated groups and housed in cages each containing five individuals. Parasites were collected by cardiac puncture in a heparinized syringe from a donor mouse harboring about 15% parasitemia. The blood was diluted with 0.9% NaCl solution to final concentrations of 1ϫ10 6 infected erythrocytes/0.2 ml of infecting suspension. Test compounds were prepared at doses of 2.5-20 mg/kg in 0.9% NaCl solution (Otsuka Pharmaceutical Co., Ltd.) or olive oil. Five animals were treated with each dose. Initially, each mouse was inoculated intravenously in the tail vein with 1ϫ10 6 parasitized erythrocytes (infecting suspension in 0.2 ml of 0.9% NaCl solution). The compounds were administrated once a day starting on day 0 and continued on day 1, day 2, and day 3. The first administration of test compound intraperitoneally started 2 h after parasite inoculation. Parasitemia levels were determined on the day following the last treatment (on day 4). To evaluate the antimalarial activity of the compounds, we prepared tail blood smears and stained them with Giemsa (E. Merck, Germany). Total 1ϫ10 4 erythrocytes/1 thin blood film were examined under microscopy. On day 4, parasitemia of control mice were between 20% and 50%. The suppression of parasitemia for the tested compounds was calculated by the formula: [(average % parasitemia in controls (sham-treated)Ϫaverage % parasitemia, in treated mice)/average % parasitemia in controls (sham-treated)]ϫ100. Five infected, 0.9% NaCl solution (or olive oil)-dosed mice were used as a control. The care and treatment of mice were in accordance with the guidelines (No. 141, 1987) issued by the Science and International Affairs Bureau of the Japanese Ministry of Education, Culture, Science and Technology.
